Seegene
Business Services · South Korea · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
Taewon Bldg 91 Ogeum-ro, Seoul, Seoul, S...Phone Number
(925) 448-8172Website
www.seegene.comRevenue
$264.5 MillionStock Symbol
096530Industry
About Seegene
Seegene Org Chart
Is Seegene your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Seegene, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Seegene launches new products
Earning: See what the market has to say on Seegene recently announced quarterly report
Click to see if Seegene had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Seegene
Funding: Get notified immidiatlly once Seegene has new funding data
Check out if Seegene is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check if Seegene has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Seegene
Find more new buyers
Company Profile Activity
Activity Insights
Seegene is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Seegene is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Seegene.
Seegene Tech Stack
A closer look at the technologies used by Seegene
Most Recent Scoops
Seegene News & Media
Seegene USA Receives FDA Emergency Use Authorization for Multiplex PCR Assay, Advancing Differential Diagnosis of HSV-1&2, VZV, and Monkeypox Virus for Ulcerative Skin Lesions
Seegene USA's Allplex™ HSV-1&2/VZV/MPXV Assay receives Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) The multiplex real-time PCR assay is designed to simultaneously detect and differentiate herpes simplex virus types 1 and 2 (HSV-1 and HSV-2),...Seegene: "Virus-Only Testing May Miss Pneumonia-associated Bacterial Respiratory Pathogens" Calls for a Shift to Comprehensive Syndromic PCR Testing
Virus-only testing may miss pneumonia-associated bacterial co-detections in 78% of virus-positive cases, while bacteria-only testing may miss viral co-detections in 88% of cases positive for pneumonia-associated bacterial pathogens Global Million Clinical Study (GMCS) to build clinical...Seegene Launches Industry's First Global Million Clinical Study to Shape New Disease-Specific Testing Standards
Seegene is launching the Global Million Clinical Study at the scale of one million test cases to shape disease-specific testing standards. The study is designed to evaluate the clinical utility of syndromic PCR testing approaches and build real-world scientific evidence to support...Seegene Launches Allplex™ MDRO Assay Under IVDR: Expanding AMR Testing Portfolio in Europe
Broadens testing scope from antimicrobial-resistant enteric bacteria to high-risk multidrug-resistant organisms (MDROs) in hospital settings Supports rapid first-line PCR screening to help enable timely infection prevention and control responses in hospital settings Expands Seegene's...
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Seegene
Seegene was founded in 2000. This company provides the developing of multiplex molecular technologies and multiplex clinical molecular diagnostics (M-MoDx). Their headquarters are located in Seoul, South Korea.... Read More